|
MLXIP expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.052600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.838300E-02 |
| Normal-vs-Stage2 |
3.206000E-01 |
| Normal-vs-Stage3 |
9.381200E-01 |
| Normal-vs-Stage4 |
5.426800E-01 |
| Stage1-vs-Stage2 |
2.372200E-02 |
| Stage1-vs-Stage3 |
7.249900E-02 |
| Stage1-vs-Stage4 |
4.342200E-01 |
| Stage2-vs-Stage3 |
3.965000E-01 |
| Stage2-vs-Stage4 |
1.962630E-01 |
| Stage3-vs-Stage4 |
5.135200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.368600E-01 |
| Normal-vs-AfricanAmerican |
1.235970E-01 |
| Normal-vs-Asian |
1.350810E-01 |
| Caucasian-vs-AfricanAmerican |
1.487810E-01 |
| Caucasian-vs-Asian |
1.977790E-02 |
| AfricanAmerican-vs-Asian |
1.577050E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.656600E-01 |
| Normal-vs-Female |
2.209400E-01 |
| Male-vs-Female |
4.866600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.874800E-01 |
| Normal-vs-Age(41-60Yrs) |
7.202200E-02 |
| Normal-vs-Age(61-80Yrs) |
7.596200E-01 |
| Normal-vs-Age(81-100Yrs) |
1.056020E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.124000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.320200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.564610E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.901900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.222900E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.767900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.422680E-04 |
| Normal-vs-Grade 2 |
1.959980E-01 |
| Normal-vs-Grade 3 |
8.815600E-01 |
| Normal-vs-Grade 4 |
2.792000E-01 |
| Grade 1-vs-Grade 2 |
2.021900E-02 |
| Grade 1-vs-Grade 3 |
9.627300E-04 |
| Grade 1-vs-Grade 4 |
3.749500E-02 |
| Grade 2-vs-Grade 3 |
1.113040E-01 |
| Grade 2-vs-Grade 4 |
8.638000E-01 |
| Grade 3-vs-Grade 4 |
2.147200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.355200E-01 |
| Normal-vs-ccB subtype |
3.326000E-02 |
| ccA subtype-vs-ccB subtype |
4.921700E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.245200E-01 |
| Normal-vs-N1 |
4.053600E-01 |
| N0-vs-N1 |
4.747000E-01 |
|
|
